Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $10,668 - $17,091
5,443 Added 21.21%
31,108 $64,000
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.64 $3,650 - $7,413
-2,808 Reduced 9.86%
25,665 $50,000
Q1 2022

May 13, 2022

BUY
$2.35 - $3.47 $54,886 - $81,045
23,356 Added 456.44%
28,473 $70,000
Q4 2021

Feb 11, 2022

BUY
$2.92 - $5.74 $14,941 - $29,371
5,117 New
5,117 $16,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.